Original-Research: ATOSS Software SE (von NuWays AG): BUY




27.04.26 09:00
dpa-AFX

^


Original-Research: ATOSS Software SE - from NuWays AG



27.04.2026 / 09:00 CET/CEST


Dissemination of a Research, transmitted by EQS News - a service of EQS


Group.


The issuer is solely responsible for the content of this research. The


result of this research does not constitute investment advice or an


invitation to conclude certain stock exchange transactions.



---------------------------------------------------------------------------



Classification of NuWays AG to ATOSS Software SE



Company Name: ATOSS Software SE


ISIN: DE0005104400



Reason for the research: Update


Recommendation: BUY


Target price: EUR 134


Target price on sight of: 12 months


Last rating change:


Analyst: Philipp Sennewald



Strong start into FY26; Guidance already upgraded



On Friday, ATOSS released strong Q1 results that confirmed the company's


ability to compound top-line growth and profitability in parallel, prompting


management to lift its full-year margin guidance already. In detail:



Group sales rose 11% yoy to EUR 51.4m (eNuW: EUR 51.9m), driven mainly by


software (+13% yoy to EUR 38.3m). Once again, Cloud & Subscriptions


accelerated significantly to EUR 27.0m (+27% yoy), now accounting for 53% of


total sales (Q1 25: 46%), while license revenues continued their planned


compression to just EUR 1.6m (-40% yoy), reflecting the ongoing successful


migration of customers towards recurring cloud contracts. Together with


maintenance, recurring revenues reached EUR 36.7m (+17% yoy), lifting the


recurring share to 71%, reflecting a 3pp yoy improvement.



The cloud ARR trajectory remains the most important forward indicator. Cloud


ARR grew 27% yoy to EUR 110m, supported by a net retention rate of 112% (+1pp


yoy). The 12-month cloud order backlog rose 23% yoy to EUR 114m, while the


total ARR backlog climbed 16% yoy to EUR 152.5m. New ACV came in at EUR 21.5m


(flat yoy), with new logos accounting for ~50% of contracts signed.


Healthcare is gaining additional traction as a vertical, contributing a


significant share of new business. During the CC, management stated the flat


ACV is in-line with budget and thus baked in the FY26 top-line guidance (c.


EUR 215m). Should the current (macro-related) elongation of sales cycle ease,


this could imply upside to the current outlook.



On profitability, EBIT reached EUR 18.2m, corresponding to a 35.3% margin


(eNuW: EUR 17.9m), once more reflecting ATOSS' disciplined cost management and


the operating leverage inherent in the SaaS model. A revaluation of the


long-term incentive programme had a marginal accretive impact on the


quarter. FCF surged 97% yoy to EUR 39.4m, reflecting front-loaded cloud


billings and a normalisation of tax outflows vs. Q1 2025, which had been


inflated by one-off back taxes. Liquidity reached EUR 162.1m, providing the


company with ample strategic flexibility for further organic investments


into AI or potential bolt-on acquisitions, while organic growth alone


remains sufficient to drive value creation with ROICs well above 50%.



On AI, ATOSS targets two near-term deliverables: the agentic ATC assistant


launching in Q2 2026 and thetwo new Agents for ASES, both due in Q4 2026.


The latter allows workers to describe complex scheduling needs, even by


voice, with the agent checking all applicable rules and surfacing compliant


options autonomously. Strategically, AI is proving a pull-forward catalyst


for cloud migration with early adoption trends across healthcare and retail


suggesting the product roadmap is resonating with the installed base.



Management confirmed FY26 sales guidance of ~EUR 215m and lifted the EBIT


margin target to >=34% (previously >=32%), which we already flagged in


previous notes and hence regard as reasonable given the strong start into


the year.



Reiterate BUY with a new EUR 134 PT (old: EUR 148) based on DCF.



You can download the research here:


https://eqs-cockpit.com/c/fncls.ssp?u=bcc3eaf22c7a75b2a9dc599a0a795f07


For additional information visit our website:


https://www.nuways-ag.com/research-feed



Contact for questions:


NuWays AG - Equity Research


Web: www.nuways-ag.com


Email: research@nuways-ag.com


LinkedIn: https://www.linkedin.com/company/nuwaysag


Adresse: Mittelweg 16-17, 20148 Hamburg, Germany


++++++++++


Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss


bestimmter Börsengeschäfte.


Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben


analysierten Unternehmen befindet sich in der vollständigen Analyse.


++++++++++



---------------------------------------------------------------------------



The EQS Distribution Services include Regulatory Announcements,


Financial/Corporate News and Press Releases.


View original content:


https://eqs-news.com/?origin_id=6b136f41-4202-11f1-8534-027f3c38b923&lang=en



---------------------------------------------------------------------------



2315116 27.04.2026 CET/CEST



°










 
 
hier klicken zur Chartansicht

Aktuelle Kursinformationen mehr >
Kurs Vortag Veränderung Datum/Zeit
82,00 € 83,10 € -1,10 € -1,32% 27.04./19:30
 
ISIN WKN Jahreshoch Jahrestief
DE0005104400 510440 159,80 € 72,40 €
Handelsplatz Letzter Veränderung  Zeit
 
Tradegate (RT)
82,00 € -1,32%  19:30
Frankfurt 84,00 € -0,47%  10:11
Düsseldorf 81,70 € -0,73%  16:31
Xetra 81,50 € -0,85%  17:35
Stuttgart 81,60 € -1,21%  19:01
Hannover 82,60 € -2,59%  08:16
Hamburg 82,60 € -3,05%  08:16
München 83,60 € -3,58%  09:15
  = Realtime
Aktien des Tages

Meistgelesene Artikel
Aktuelle Diskussionen
RSS Feeds




Bitte warten...